EUVIMEDEUVIMED entdecken
Open Access

HIV/Hepatitis Prevention in Drug Abuse Treatment Programs: Guidance From Research

James L Sorensen, Carmen L Masson, David C Perlman

Science & Practice Perspectives · 2002

DOI: 10.1151/spp02114 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science & Practice Perspectives, 2002. Verfasst von James L Sorensen und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of California, San Francisco, San Francisco General Hospital, San Francisco, California 94110, USA. james@itsa.ucsf.edu. Die Arbeit wurde bisher 23-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Community-Institutional RelationsCounselingHIV InfectionsHealth PromotionHepatitis, Viral, HumanHumansMass ScreeningPatient Education as TopicRisk AssessmentSubstance Abuse, IntravenousUnited StatesVaccination

Autor:innen und Institutionen

  • University of California, San Francisco, San Francisco General Hospital, San Francisco, California 94110, USA. james@itsa.ucsf.edu

Förderung

  • NIDA NIH HHS

Zitieren

APA

Sorensen, J. L., Masson, C. L., & Perlman, D. C. (2002). HIV/Hepatitis Prevention in Drug Abuse Treatment Programs: Guidance From Research. Science & Practice Perspectives. https://doi.org/10.1151/spp02114

Vancouver

Sorensen JL, Masson CL, Perlman DC. HIV/Hepatitis Prevention in Drug Abuse Treatment Programs: Guidance From Research. Science & Practice Perspectives. 2002. doi:10.1151/spp02114

BibTeX
@article{Sorensen2002,
  author = {Sorensen, James L and Masson, Carmen L and Perlman, David C},
  title = {HIV/Hepatitis Prevention in Drug Abuse Treatment Programs: Guidance From Research},
  journal = {Science & Practice Perspectives},
  year = {2002},
  doi = {10.1151/spp02114}
}
Kostenlos starten →